Biotechnology - CytomX Therapeutics


Current filters:

CytomX Therapeutics

Popular Filters

CytomX and ImmunoGen announce collaboration to develop Probody-Drug Conjugates against cancer targets


US biotech firms CytomX Therapeutics and ImmunoGen (Nasdaq: IMGN) have signed a collaboration agreement…

BiotechnologyCytomX TherapeuticsImmunoGenLicensingOncologyResearchUSA

CytomX signs up to $635 million oncology deal with Pfizer


US biotech firm CytomX Therapeutics, which is developing a new generation of targeted antibody therapeutics,…

BiotechnologyCytomX TherapeuticsLicensingOncologyPfizerPharmaceuticalResearch

Back to top